Stonepine Capital Management’s Corvus Pharmaceuticals CRVS Stock Holding History

Stonepine Capital Management’s Portfolio CRVS Stock Details CRVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-46,886	Closed	-$125K	–	32
2021 Q2	$125K	Sell	46,886 -269,393	-85%	-$742K	0.07%	24
2021 Q1	$974K	Buy	+316,279	New	+$1.14M	0.53%	25

Other funds holding CRVS

OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ikarian Capital Dallas, Texas $699M AUM 600.17% 1-Year Est. Return

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return